Product Details
Product Name:
MK-8033 hydrochloride |
CAS No.:
1283000-43-0 |
Supply Ability:
10g |
Release date:
2025/07/19 |
Product Introduction
Bioactivity
Name | MK-8033 hydrochloride |
Description | MK-8033 hydrochloride is an effective and orally active dual inhibitor of ATP competitive c-Met/Ron, with 1 nM for c-Met and 7nM for Ron IC50. MK-8033 hydrochloride has a high affinity for activated kinase conformation, and is suitable for the study of breast cancer, bladder cancer, and non-small cell lung cancer (NSCLC). |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Solubility Information | DMSO : < 1 mg/mL (insoluble or slightly soluble)
|
Keywords | MK-8033 Hydrochloride | MK8033 Hydrochloride | MK8033 hydrochloride | MK 8033 Hydrochloride | MK 8033 hydrochloride |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries, 10000+ Noval Small Molecucles,16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
CAS:189954-93-6
$1670.00 / 25mg
-
CAS:60559-92-4
$1980.00 / 50mg
-
CAS:719274-77-8
$2580.00 / 50mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$0.00/10g |
VIP1Y
|
Wuhan Kejiefeng Trading Co.,Ltd
|
2025-05-07 |
|
$5.00/1Box |
VIP1Y
|
Hebei Jiafan Trading Company Limited
|
2025-01-08 |